MicroMRI Closes New Round of Funding

Led by Cahn Medical Technologies, MicroMRI this month closed its A-2 financing. The funding is planned to carry the company until late 2009. Well before that point, it expects to achieve two major milestones that will enable the company to raise significant additional financing from new investors.

About MicroMRI
Based in Philadelphia (Pennsylvania, USA), MicroMRI, Inc. is a medical device company focused on developing and commercializing novel products that perform high-resolution Magnetic Resonance Imaging (MRI) of bone trabecular microarchitecture and subsequent computer assisted quantitative modeling of bone quality and bone strength. In 2003, MicroMRI was founded with a license of a technology developed by the University of Pennsylvania and intends to develop a commercial product for clinical routine use that can be used in the diagnosis of osteoporosis as well as in the assessment of treatment effects of pharmaceuticals improving bone structure and quality. Significant clinical value comes from a the computer assisted analysis of bone microarchitecture and its quantitative output of clinically relevant parameters. More information about the Company or its technology can be obtained by visiting www.micromri.com, by calling our office at 215.564.1002 or send an email to info@micromri.com.